A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation

Blood

Volumn 102, Issue 10, 2003, Pages 3807-3814

  Bozza, Silvia ^b   Perruccio, Katia ^b   Montagnoli, Claudia ^b   Gaziano, Roberta ^b   Bellocchio, Silvia ^b   Burchielli, Emanuela ^b   Nkwanyuo, Gabriel ^b   Pitzurra, Lucia ^b   Velardi, Andrea ^b   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL RNA; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; VACCINE;

ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BONE MARROW CELL; CELL ACTIVATION; CONIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FUNGUS HYPHAE; FUNGUS IMMUNITY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; INFECTION SENSITIVITY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

EID: 0242578106     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0748     Document Type: Article

References (42)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-805.
2. Marr KA, Patterson T, Denning D. Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am. 2002;16:875-894.
3. Fukuda T, Boeckh M, Carter RA, et al. Invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplantation after nonmyeloablative conditioning: risks and outcomes. Blood. In press.
4. Marino IR, Panarello G, Singh N. Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl Infect Dis. 2002;4:226-227.
5. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358-4366.
6. Grow WB, Moreb JS, Roque D, et al. Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 2002;29:15-19.
7. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:654-662.
8. Roilides E, Katsifa H, Walsh TJ. Pulmonary host defenses against Aspergillus fumigatus. Res Immunol. 1998;149:454-465.
9. Cenci E, Mencacci A, Fe'd'Ostiani C, et al. Cytokine and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis. 1998;178:1750-1760.
10. Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup VP, Romani L. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol. 2000; 165:381-388.
11. Latgé JR. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001;9:382-389.
12. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002;420:182-186.
13. BitMansour A, Burns SM, Traver D, et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood. 2002;100:4660-4667.
14. Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematological malignancies. Blood. 2002;100: 4521-4527.
15. Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J Infect Dis. 1997;176:1579-1583.
16. Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol. 2002;168:1362-1371.
17. Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect. 2002;4:1281-1290.
18. Holt PG, Stumbles PA, McWilliam AS. Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J Leuk Biol. 1999; 66:272-275.
19. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol. 2001;2:725-731.
20. Fè d'Ostiani C, Del Sero G, Bacci A, et al. Dendritic cells discriminate between yeast and hyphae of the fungus Candida albicans: implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med. 2000;15:1661-1674.
21. Bacci A, Montagnoli C, Perruccio K, et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol. 2002;168:2904-2913.
22. Mencacci A, Perruccio K, Bacci A, et al. Defective antifungal T-helper 1 (TH1) immunity: a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood. 2001;97: 1483-1490.
23. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med. 2001;194:863-869.
24. Ebner S, Hofer S, Nguyen VA, et al. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol. 2002;168:6199-6207.
25. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Immunol. 2002;2:151-161.
26. Walker C, Selby M, Erikson A, Cataido D, Valensi JP, van Nest G. Cationic lipids direct a viral glyco-protein into the class I major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci U S A. 1992;89:7915-7918.
27. +) cell population in the reconstitution phase after human bone marrow transplantation. Blood. 1988;71:1196-1200.
28. Stordeur P, Poulin LF, Cracium L, et al. Cytokine mRNA quantification by real-time PCR. J Immunol Methods. 2002;259:55-64.
29. Grazziutti M, Przepiorka D, Rex JH, Braunschweig I, Vadhan-Raj S, Savary CA. Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus. Bone Marrow Transplant. 2001;27:647-652.
30. Golschneider I, Cone RE. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance. Trends Immunol. 2003;24: 77-81.
31. Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest. 2002; 109:1519-1526.
32. Roux EC, Helg F, Dumond-Girard B, Chapius MJ, Roosnek E. Analysis of T cell repopulation after allogeneic marrow transplantation: significant differences between recipients of T cell depleted and unmanipulated grafts. Blood. 1996;272:1755-1762.
33. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow: increased susceptibility to fungal infections. Ann Intern Med. 1986;104:619-631.
34. Verfuerth SK, Peggs PV, Barnett L, O'Reilly RJ, Mackinnon S. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusion on T-cell repertoire. Blood. 2000;95:3990-3995.
35. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation-friend or foe? Immunity. 2001; 14:357-368.
36. Pawloweska AB, Hashino S, McKenna H, Weigel BJ, Taylor PA, Blazar BR. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice. Blood. 2001;97:1474-1482.
37. Rossi M, Arpinati M, Rondelli D, Anasetti C. Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation? Hum Immunol. 2002;63:1194-1200.
38. Bacchetta R, Bigler M, Touraine J, et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med. 1994;179:493-502.
39. Hara M, Kingsley CI, Masanori N, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 2001; 166:3789-3796.
40. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host-disease lethality. Blood. 2002;15:3493-3499.
41. + regulatory T cells are essential components of the memory protective immunity to Candida albicans. J Immunol. 2002; 169:6298-6308.
42. Perruccio K, Tosti A, Posati S, et al. Transfer of functional immune responses to Aspergillus and CMV after haploidentical hematopoietic transplantation [abstract]. Blood. 2000;96:555a.